M Share Price Performance
RON 0
-8.13 (-100.00%)
Price RON 0
Fair ValueRON 12.50
Share Pricen/a
Narrative Update • Aug 13
Med Life S.A. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 30 Fair Values set on narratives written by author
M Community Narratives
AN
Fair Value
·Fair Value RON 12.5 9.0% undervalued intrinsic discount
High-Complexity Healthcare Expansion And Digitalization Will Support Long-Term Earnings Potential
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value RON 7.1 60.3% overvalued intrinsic discount
Genomics Expansion And Rising CapEx Will Pressure Margins And Future Earnings
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value RON 10.67 6.7% overvalued intrinsic discount
Future Expansion Into Complex Services Will Strain Margins And Limit Earnings Potential
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Future Expansion Into Complex Services Will Strain Margins And Limit Earnings Potential
Med Life is betting on more advanced hospital and lab services, but that shift could bring higher running costs that are hard to pass on to patients and employers. With expansion and new tech spending also raising the fixed cost base, the key question is whether demand stays strong enough to keep profits from being squeezed.Read more
AN
RON 10.67
6.7% overvalued intrinsic discount
Fair Value
Revenue
10.43% p.a.
Profit Margin
6.95%
Future PE
26.58x
Price in 2029
RON 15.22
High-Complexity Healthcare Expansion And Digitalization Will Support Long-Term Earnings Potential
Med Life is pushing deeper into complex treatments and new tech like robotics, genetics, and digital tools, aiming to become a bigger part of patients’ healthcare journeys and improve how efficiently care is delivered. But the bet comes with real risks: weaker consumer demand, heavy spending on new facilities and equipment, and funding or currency pressures could limit how much this expansion pays off.Read more
AN
RON 12.5
9.0% undervalued intrinsic discount
Fair Value
Revenue
11.21% p.a.
Profit Margin
7.78%
Future PE
27.18x
Price in 2029
RON 17.8
Genomics Expansion And Rising CapEx Will Pressure Margins And Future Earnings
Med Life is betting big on new, more complex healthcare services and a bigger tech platform, but that spending could keep profits under pressure if demand doesn’t rise fast enough. See why expansion, debt costs, and currency swings could matter as much as patient growth for where the business goes next.Read more
AN
RON 7.1
60.3% overvalued intrinsic discount
Fair Value
Revenue
11.11% p.a.
Profit Margin
7.58%
Future PE
15.97x
Price in 2029
RON 10.16
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
nan
Fair Value: RON 10.67 6.7% overvalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
M: Fairly Priced Outlook Will Rely On Steady Margins And P/E Assumptions
Fair Value: RON 12.5 9.0% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Genomics Expansion And Rising CapEx Will Pressure Margins And Future Earnings
Fair Value: RON 7.1 60.3% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Med Life S.A. Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 28, 2026
- 0.014
- 48.48%
- 0.24%
- 272.9%
About M
- Founded
- 1996
- Employees
- 6744
- CEO
- WebsiteView website
Med Life S.A., a private healthcare provider, provides integrated medical services through its clinics and hospitals in Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging tests; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides laboratory services, such as biochemistry, pathological anatomy, molecular biology and genetics, hematology, immunology, microbiology, cytology, and toxicology; healthcare packages; a range of dental services; and fitness services and wellness facilities through the Sweat Concept network and Sanopass platform. In addition, the company is involved in the development of building projects; insurance broker; rental activities; and distribution and retail sale of pharmaceutical products in specialized stores. Med Life S.A. was incorporated in 1996 and is headquartered in Bucharest, Romania.